Expertise in
18
conditions

Yong-jin W. Kim

Seoul, KR 
Expertise in
18
conditions
Seoul, KR 
OverviewLocationsClinical Research

Overview

Yong-jin Kim practices in Seoul, Republic of Korea. Kim is highly rated in 18 conditions, according to our data. Their top areas of expertise are Hypertrophic Cardiomyopathy (HCM), Coronary Heart Disease, Cardiomyopathy, Sleeve Gastrectomy, and Gastric Bypass.

Their clinical research consists of co-authoring 425 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Locations

Seoul, Republic of Korea
Other Locations
Daegu, Republic of Korea
Yuseong, Republic of Korea
Waegwan, Republic of Korea
Daejeon, Republic of Korea
Nakdong River Environment Research Center, Daegu 43008, Nakdong, Republic of Korea
Changwon, Republic of Korea
R&D Unit, Yongin, Republic of Korea
Gyeonggi-do, Republic of Korea
Ulsan, Republic of Korea
Yangsan, Republic of Korea
Busan, Republic of Korea
Jeonju, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Multicenter, Randomized, 2 x 2 Factorial, Phase 3 Study to Assess the Efficacy of Carvedilol and Empagliflozin on Improvement of Right Ventricular Remodeling in Patients With Severe Functional Tricuspid Regurgitation
Multicenter, Randomized, 2 x 2 Factorial, Phase 3 Study to Assess the Efficacy of Carvedilol and Empagliflozin on Improvement of Right Ventricular Remodeling in Patients With Severe Functional Tricuspid Regurgitation
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug
Study Drugs: Carvedilol+Empagliflozin, Carvedilol, Empagliflozin
Study Phase: Phase 3
Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy of Ertugliflozin on Reduction of Mitral Regurgitation in Patients With Functional Mitral Regurgitation Secondary to Left Ventricular Dysfunction
Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Assess the Efficacy of Ertugliflozin on Reduction of Mitral Regurgitation in Patients With Functional Mitral Regurgitation Secondary to Left Ventricular Dysfunction
Enrollment Status: Completed
Publish Date: January 06, 2025
Intervention Type: Drug
Study Drug: Ertugliflozin
Study Phase: Phase 3
A Multicenter, Double-blind, Placebo-controlled, Stratified-randomized, Parallel, Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-1229 in Patients With Calcific Aortic Valve Disease
A Multicenter, Double-blind, Placebo-controlled, Stratified-randomized, Parallel, Therapeutic Exploratory Clinical Study to Evaluate the Efficacy and Safety of DA-1229 in Patients With Calcific Aortic Valve Disease
Enrollment Status: Completed
Publish Date: March 03, 2023
Intervention Type: Drug
Study Drug: DA-1229
Study Phase: Phase 2
View 2 Less Clinical Trials

425 Total Publications

Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study.
Pericoronary Adipose Tissue Attenuation in Patients with Future Acute Coronary Syndromes: The ICONIC Study.
Journal: Radiology. Cardiothoracic imaging
Published: June 20, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kim's expertise for a condition
ConditionClose
    View All 14 Advanced Conditions
    View All 69 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile